PHS
PFE icon

Pekin Hardy Strauss’s Pfizer PFE Stock Holding History

Pekin Hardy Strauss’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,000
Closed -$204K – 326
2023
Q1 		$204K Buy
+5,000
New +$216K 0.03% 276

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Pekin Hardy Strauss's PFE Position: Q2 2026 in Review

Pekin Hardy Strauss reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $62.6K and leaving 9,923 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #433.

Pekin Hardy Strauss first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.34M in Q4 2021. 1,596 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pekin Hardy Strauss held 9,923 shares of Pfizer worth $239K as of Q2 2026.
  • Pekin Hardy Strauss sold 2,392 Pfizer shares in Q2 2026, an estimated $62.6K.
  • Pfizer made up 0.02% of Pekin Hardy Strauss's portfolio in Q2 2026, its #433 holding.
  • Pekin Hardy Strauss first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Pekin Hardy Strauss's Pfizer position peaked at $4.34M in Q4 2021.
  • 1,596 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.